PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.
-3.61%
Negative ROE while Healthcare median is -3.70%. Seth Klarman would investigate if capital structure or industry issues are at play.
-2.78%
Negative ROA while Healthcare median is -5.73%. Seth Klarman would consider if assets are underutilized or if it’s a distressed opportunity.
-2.32%
Negative ROCE while Healthcare median is -4.74%. Seth Klarman would investigate whether a turnaround is viable.
36.46%
Gross margin 75-90% of Healthcare median of 45.35%. John Neff would look for incremental cost improvements.
-48.85%
Negative operating margin while Healthcare median is -6.09%. Seth Klarman would look for a path to operational turnaround.
-65.05%
Negative net margin while Healthcare median is -8.35%. Seth Klarman would see if cost cuts or revenue growth can fix losses.